Skip to main content

Navigation group

Type at least 3 characters
1,031 articles

Articles

Brief Research Report

Published on 06 Jun 2022

Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12

in Cancer Genetics and Oncogenomics

  • Dolores Gallardo-RincĂłn
  • Edgar Montes-ServĂ­n
  • Gabriela Alamilla-GarcĂ­a
  • Elizabeth Montes-ServĂ­n
  • Antonio Bahena-González
  • Lucely Cetina-PĂ©rez
  • Flavia Morales Vásquez
  • Claudia Cano-Blanco
  • Jaime Coronel-MartĂ­nez
  • Ernesto González-Ibarra
Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12
Frontiers in Genetics
doi 10.3389/fgene.2022.863956
  • 2,963 views
  • 3 citations